SubPart 5. fees relating to generic new animal drugs  


§ 379j–21. Authority to assess and use generic new animal drug fees
§ 379j–22. Reauthorization; reporting requirements

Prospective Amendment

Termination of Subpart

For termination of subpart by section 206(a), (b) of Pub. L. 113–14, see Termination Date notes set out under sections 379j–21 and 379j–22 of this title.